| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | M A Feitelson | |
| L X Duan | |||
| P2860 | cites work | TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas | Q43826975 |
| Regulation of insulin-like growth factor II Gene expression by hepatitis B virus in hepatocellular carcinoma | Q43874896 | ||
| Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver | Q44101756 | ||
| HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions | Q44489320 | ||
| Wild-type p53 binds to the TATA-binding protein and represses transcription | Q24300991 | ||
| Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation | Q24310197 | ||
| Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma | Q24563988 | ||
| Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 | Q24564855 | ||
| Proteasome complex as a potential cellular target of hepatitis B virus X protein | Q24681896 | ||
| Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma | Q28241770 | ||
| Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
| Amplification of a gene encoding a p53-associated protein in human sarcomas | Q28270924 | ||
| The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
| Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma | Q28287494 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
| Polymerase II promoter activation: closed complex formation and ATP-driven start site opening | Q28646720 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia | Q29615437 | ||
| The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B | Q29618194 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor | Q29619833 | ||
| Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls | Q33765576 | ||
| Hepatitis B virus X gene can transactivate heterologous viral sequences | Q33845263 | ||
| Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan | Q34054719 | ||
| Abrogation of p53-induced apoptosis by the hepatitis B virus X gene | Q34367126 | ||
| Hepatocarcinogenicity of the woodchuck hepatitis virus | Q34594377 | ||
| Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. | Q34673509 | ||
| Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 | Q35101216 | ||
| Hepatocellular carcinoma: Recent progress | Q35227361 | ||
| Hepatitis B virus infection and primary hepatocellular carcinoma | Q35231554 | ||
| Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus | Q35612599 | ||
| Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation | Q35835238 | ||
| Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade | Q35850088 | ||
| Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication | Q35866048 | ||
| Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus | Q35885615 | ||
| Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei | Q35992152 | ||
| Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator | Q36100142 | ||
| The p53 tumor suppressor protein, a modulator of cell proliferation | Q36362434 | ||
| Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA | Q36488685 | ||
| Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. | Q36508624 | ||
| Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver | Q36598907 | ||
| Woodchuck hepatitis virus X protein is required for viral infection in vivo | Q36630766 | ||
| The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. | Q36642780 | ||
| Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. | Q36655403 | ||
| p53-mediated cell death: relationship to cell cycle control | Q36675212 | ||
| Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host | Q36683401 | ||
| Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice | Q36698569 | ||
| Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice | Q36796019 | ||
| Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication | Q36830695 | ||
| Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers | Q36872573 | ||
| Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions | Q36878776 | ||
| DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice | Q37326913 | ||
| Degradation of nuclear oncoproteins by the ubiquitin system in vitro | Q37361143 | ||
| Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat | Q37565289 | ||
| Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus | Q37599222 | ||
| Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA | Q37608976 | ||
| Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association | Q37833427 | ||
| The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses | Q37855772 | ||
| Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. | Q37894884 | ||
| Putting it on and taking it off: phosphoprotein phosphatase involvement in cell cycle regulation | Q38274350 | ||
| Functional inactivation but not structural mutation of p53 causes liver cancer. | Q38300638 | ||
| Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway | Q38321449 | ||
| Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization | Q38327000 | ||
| Hepatitis B virus gene products as immunological targets in chronic infection | Q38770452 | ||
| Hepatitis B virus. The major etiology of hepatocellular carcinoma | Q39199064 | ||
| Prooxidant states and tumor promotion | Q39492603 | ||
| Chronic type B hepatitis and the "healthy" HBsAg carrier state | Q39662797 | ||
| Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. | Q39873599 | ||
| Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells | Q39876155 | ||
| The X protein of hepatitis B virus coactivates potent activation domains | Q40021717 | ||
| Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C | Q40064034 | ||
| Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts | Q40345663 | ||
| Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis | Q40386904 | ||
| Oxidative mechanisms in carcinogenesis | Q40771862 | ||
| A comparison of the biological activities of wild-type and mutant p53. | Q40831456 | ||
| Antiviral therapy of chronic hepatitis B: past, present, and future | Q40915924 | ||
| pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner | Q41075171 | ||
| Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. | Q41205751 | ||
| Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA | Q41206745 | ||
| X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum | Q41225239 | ||
| X antigen polypeptides in the sera of hepatitis B virus-infected patients | Q41232256 | ||
| Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. | Q41437081 | ||
| Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways | Q41487392 | ||
| Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation | Q41532796 | ||
| Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents | Q41575832 | ||
| Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis | Q41675964 | ||
| In vitro tumorigenicity of hepatitis B virus DNA and HBx protein | Q41705071 | ||
| Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice | Q41736950 | ||
| Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors | Q41742365 | ||
| Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice | Q41757834 | ||
| Identification of human ventricular myosin heavy chain fragments with monoclonal antibody 2F4 in human sera after myocardial necrosis | Q41878123 | ||
| Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma | Q42027794 | ||
| Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis | Q42478545 | ||
| The 17 kDa HBx protein encoded by hepatitis B virus interacts with the activation domains of Oct-1, and functions as a coactivator in the activation and repression of a human U6 promoter. | Q42500514 | ||
| Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product. | Q42519906 | ||
| Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus | Q42624587 | ||
| Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks | Q43470081 | ||
| Expression of insulin-like growth factor II, α-fetoprotein and hepatitis B virus transcripts in human primary liver cancer | Q43494203 | ||
| The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. | Q44779333 | ||
| Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies | Q44990068 | ||
| The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells | Q45166424 | ||
| Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma | Q45279592 | ||
| Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system | Q45771119 | ||
| Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication | Q45771158 | ||
| Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication | Q45776308 | ||
| Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. | Q45776760 | ||
| High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice | Q45779177 | ||
| The X protein of hepatitis B virus has a ribo/deoxy ATPase activity | Q45781571 | ||
| Hepatitis B virus X gene product acts as a transactivator in vivo. | Q45782366 | ||
| Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression | Q45783000 | ||
| Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks | Q45799782 | ||
| A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state | Q45840310 | ||
| Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma | Q45840313 | ||
| Feasibility of controlling or eradicating the hepatitis B virus | Q45843147 | ||
| Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse | Q45843701 | ||
| Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. | Q45846130 | ||
| Monoclonal antibodies raised to purified woodchuck hepatitis virus core antigen particles demonstrate X antigen reactivity | Q45849139 | ||
| Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis | Q45849190 | ||
| The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase | Q45850090 | ||
| X protein of hepatitis B virus resembles a serine protease inhibitor | Q45852144 | ||
| HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 | ||
| The interaction of RNA polymerase II with the adenovirus-2 major late promoter is precluded by phosphorylation of the C-terminal domain of subunit IIa | Q46025547 | ||
| The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen | Q46840212 | ||
| Oncogene-induced liver neoplasia in transgenic mice. | Q53515079 | ||
| Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. | Q53519243 | ||
| Stalking the start of colon cancer. | Q54637593 | ||
| The insulin-like growth factor I receptor: a key to tumor growth? | Q55481189 | ||
| The hepatitis B virus | Q59051957 | ||
| Pathogenesis of posttransfusion viral hepatitis in children with β-thalassemia | Q63236723 | ||
| Regulation of the human hsp70 promoter by p53 | Q64377885 | ||
| Hepatitis B X-gene expression in hepatocellular carcinoma | Q67507097 | ||
| HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis | Q67693862 | ||
| Effect of the Bowman-Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon | Q67995364 | ||
| Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and imununocytochemistry | Q68260062 | ||
| Products of the "X" gene in hepatitis B and related viruses | Q68957799 | ||
| The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma | Q70498398 | ||
| DNA repair. Engagement with transcription | Q70683866 | ||
| Characteristics of woodchuck hepatitis X-antigen in the livers and sera from infected animals | Q70756305 | ||
| Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro | Q71061778 | ||
| In vivo ubiquitination and proteasome-mediated degradation of p53(1) | Q71129152 | ||
| Slow DNA repair implicated in mutations found in tumors | Q72293083 | ||
| [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma] | Q72502872 | ||
| Transgenic mouse models of hepatocellular carcinoma | Q72738468 | ||
| Presence of Hepatitis B Surface Antigen Before Primary Hepatocellular Carcinoma | Q72927130 | ||
| Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver | Q72945063 | ||
| Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma | Q72966947 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| P304 | page(s) | 1141-1157 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma | |
| P478 | volume | 150 |
| Q37265609 | A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China |
| Q38271599 | A comprehensive molecular interaction map for Hepatitis B virus and drug designing of a novel inhibitor for Hepatitis B X protein |
| Q26822570 | AEG-1/MTDH/LYRIC in liver cancer |
| Q24647547 | Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression |
| Q40744258 | C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. |
| Q33618740 | C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. |
| Q33988586 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development |
| Q42010880 | Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver. |
| Q38697681 | Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-κB pathway |
| Q36415580 | Construction of eukaryotic expression vector of HBV x gene |
| Q34958145 | Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma |
| Q43119119 | Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. |
| Q34988085 | Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? |
| Q64885161 | Dysregulated fatty acid metabolism in hepatocellular carcinoma. |
| Q45371020 | Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas |
| Q28740406 | Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication |
| Q40629212 | Evidence of Hepatitis B Virus Infection in Cancer and Noncancer Stem Cells Associated with Human Hepatocellular Carcinoma |
| Q33787132 | Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice |
| Q36506290 | Expression of hepatitis B virus X protein in transgenic mice |
| Q45325156 | Expression, purification and characterization of hepatitis B virus X protein BH3-like motif-linker-Bcl-xL fusion protein for structural studies |
| Q34389709 | From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways |
| Q37311716 | HBx Gene Mutations in Hepatitis B Virus and Hepatocellular Carcinoma |
| Q38829387 | HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner |
| Q36916318 | HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress |
| Q36281598 | Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions |
| Q28384850 | Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activity |
| Q34580906 | Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system |
| Q39605979 | Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions |
| Q43669585 | Hepatitis B virus X protein in the proteasome of mammalian cells: defining the targeting domain |
| Q33649039 | Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex |
| Q36389447 | Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction |
| Q36389497 | Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans |
| Q21245106 | Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2 |
| Q45387956 | Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells |
| Q39748588 | Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells |
| Q24682883 | Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival |
| Q37195543 | Hepatitis viruses and non-Hodgkin's lymphoma: A review |
| Q43641235 | Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody |
| Q37349973 | Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer |
| Q38435353 | Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells |
| Q82621577 | Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome |
| Q43233319 | Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells |
| Q90212864 | MicroRNA-34c suppresses proliferation of vascular smooth muscle cell via modulating high mobility group box protein 1 |
| Q34053726 | Mobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogen |
| Q36743649 | Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses |
| Q36491748 | Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene |
| Q38355045 | Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal |
| Q37388018 | Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease |
| Q24320028 | Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1 |
| Q34230585 | Role of miR-148a in hepatitis B associated hepatocellular carcinoma. |
| Q33248641 | Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice |
| Q39582588 | T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. |
| Q36237549 | TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. |
| Q89497633 | Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma |
| Q24681487 | The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas |
| Q39740159 | The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression |
| Q33552832 | Transformation of human liver L-O2 cells mediated by stable HBx transfection |
| Q28073477 | Understanding the role of PIN1 in hepatocellular carcinoma |
| Q34771678 | Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis |
| Q36814387 | Viral genotypes and associated risk factors of hepatocellular carcinoma in India |
| Q30366407 | Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer |
| Q36291789 | p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation |
Search more.